Next-generation multi-target stool DNA test
Intervention1 paper3 findings
- In silico1
Outcomes
3Screening-detected colorectal cancer
upin silico1Very low certainty
1 study
Screening-detected colorectal cancer
upin silico1Very low certainty
Next-generation multi-target stool DNA test increases screening-detected colorectal cancer in silico (+17 CRCs screening-detected).
In silico3 years
Estimated cost, resource use, and health benefits of an increased use of next-generation multi-target stool DNA test for colorectal cancer screening from an integrated delivery network perspective · Journal of medical economics · 1 Oct 2026
Mortality
downin silico1Very low certainty
1 study
Mortality
downin silico1Very low certainty
Next-generation multi-target stool DNA test decreases mortality in silico (-1 death).
In silico3 years
Estimated cost, resource use, and health benefits of an increased use of next-generation multi-target stool DNA test for colorectal cancer screening from an integrated delivery network perspective · Journal of medical economics · 1 Oct 2026
CRC screening rate
upin silico1+1.1%Very low certainty
1 study
CRC screening rate
upin silico1+1.1%Very low certainty
Next-generation multi-target stool DNA test increases CRC screening rate in silico (+1.1%).
In silico3 years
Estimated cost, resource use, and health benefits of an increased use of next-generation multi-target stool DNA test for colorectal cancer screening from an integrated delivery network perspective · Journal of medical economics · 1 Oct 2026